{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:05:13Z","timestamp":1791295513511,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.heliyon.2023.e22464","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:25:16Z","timestamp":1700267116000},"page":"e22464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["TDO2 deficiency attenuates the hepatic lipid deposition and liver fibrosis in mice with diet-induced non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Zhi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.heliyon.2023.e22464_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bbrc.2015.02.046","article-title":"Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway","volume":"458","author":"Wu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22464_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5114\/ceh.2018.78118","article-title":"Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)","volume":"4","author":"Tomasiewicz","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e22464_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.25003","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"24","author":"Younossi","year":"2018","journal-title":"Liver Transplant."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22464_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22464_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e22464_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front. Biosci."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e22464_bib7","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3748\/wjg.v20.i7.1746","article-title":"Modulation of hepatic steatosis by dietary fatty acids","volume":"20","author":"Ferramosca","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22464_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12951-018-0391-9","article-title":"Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD","volume":"16","author":"Liang","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e22464_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.heliyon.2023.e22464_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2021.104733","article-title":"TGF-\u03b21 signaling can worsen NAFLD with liver fibrosis backdrop","volume":"124","author":"Ahmed","year":"2022","journal-title":"Exp. Mol. Pathol."},{"issue":"7368","key":"10.1016\/j.heliyon.2023.e22464_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22464_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-021-01080-8","article-title":"Indoleamine 2,3-dioxygenase 1 (Ido1) inhibitors in clinical trials for cancer immunotherapy","volume":"14","author":"Tang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e22464_bib13","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.apsb.2021.03.009","article-title":"Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT\/GSK3\u03b2\/IL-8 signaling pathway","volume":"11","author":"Zhao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e22464_bib14","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5362","article-title":"TDO2 modulates liver cancer cell migration and invasion via the Wnt5a pathway","volume":"60","author":"Liu","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e22464_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095203","article-title":"Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model","volume":"23","author":"Arora","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.heliyon.2023.e22464_bib16","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1021\/acs.jmedchem.1c00323","article-title":"Rational design of original fused-cycle selective inhibitors of tryptophan 2,3-dioxygenase","volume":"64","author":"Kozlova","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22464_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/s12935-021-02228-9","article-title":"Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway","volume":"21","author":"Wu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22464_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010360","article-title":"Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57bl\/6 mice model via AMPK\/Sirt1\/SREBP-1c\/PPAR\u03b3 pathway","volume":"21","author":"Chyau","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e22464_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.freeradbiomed.2020.04.009","article-title":"Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1","volume":"153","author":"Wu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e22464_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12272-021-01317-7","article-title":"LncRNA AIRN influences the proliferation and apoptosis of hepatocellular carcinoma cells by regulating STAT1 ubiquitination","volume":"44","author":"Cai","year":"2021","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e22464_bib21","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22464_bib22","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1002\/ctm2.777","article-title":"MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non-alcoholic fatty liver disease","volume":"12","author":"Luo","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22464_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/hep.24756","article-title":"Receptor activator of nuclear factor-\u03baB ligand (RANKL) protects against hepatic ischemia\/reperfusion injury in mice","volume":"55","author":"Sakai","year":"2012","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e22464_bib24","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cmet.2022.05.008","article-title":"MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metabol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22464_bib25","first-page":"893","article-title":"Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPAR\u03b3, LXR\u03b1 and ABCA1","volume":"44","author":"Jia","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e22464_bib26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e22464_bib27","first-page":"29","article-title":"Induction of TDO2 and Ido2 in liver by high-fat feeding in mice: discrepancies with human obesity","volume":"6","author":"Poulain-Godefroy","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e22464_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12388","article-title":"Melatonin regulates lipid metabolism in porcine oocytes","volume":"62","author":"Jin","year":"2017","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22464_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12944-019-1118-0","article-title":"Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis","volume":"18","author":"Yang","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.heliyon.2023.e22464_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2023.e22464_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119071","article-title":"miR-125b promotes the NF-\u03baB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3","volume":"270","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2023.e22464_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111874","article-title":"Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-\u03baB signaling pathways","volume":"141","author":"Zhao","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e22464_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113117","article-title":"Blockade of NF-\u03baB translocation and of RANKL\/RANK interaction decreases the frequency of Th2 and Th17 cells capable of IL-4 and IL-17 production, respectively, in a mouse model of allergic asthma","volume":"26","author":"Gregorczyk","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e22464_bib34","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e22464_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e22464_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101353","article-title":"STE20-type kinase TAOK3 regulates hepatic lipid partitioning","volume":"54","author":"Xia","year":"2021","journal-title":"Mol. Metabol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e22464_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/1098612X19857853","article-title":"Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis","volume":"22","author":"Valtolina","year":"2020","journal-title":"J. Feline Med. Surg."},{"issue":"10290","key":"10.1016\/j.heliyon.2023.e22464_bib38","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22464_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41419-020-2411-6","article-title":"TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice","volume":"11","author":"Wandrer","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2023.e22464_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.122588","article-title":"TCDD promotes liver fibrosis through disordering systemic and hepatic iron homeostasis","volume":"395","author":"Li","year":"2020","journal-title":"J. Hazard Mater."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22464_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NF\u03baB system","volume":"8","author":"Mitchell","year":"2016","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"10.1016\/j.heliyon.2023.e22464_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopha.2018.05.108","article-title":"Dangguishaoyao-San attenuates LPS-induced neuroinflammation via the TLRs\/NF-\u03baB signaling pathway","volume":"105","author":"Ding","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e22464_bib43","doi-asserted-by":"crossref","first-page":"902","DOI":"10.5152\/tjg.2020.19568","article-title":"Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4\/MyD88\/NF-\u03baB pathway","volume":"31","author":"Wang","year":"2020","journal-title":"Turk. J. Gastroenterol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402309672X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402309672X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:43:19Z","timestamp":1791294199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402309672X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S240584402309672X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22464","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TDO2 deficiency attenuates the hepatic lipid deposition and liver fibrosis in mice with diet-induced non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e22464"}}